Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-99b-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 232, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
HTATIP2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:20383381-20383401 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUP98 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:3699226-3699247 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HPS5 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:18297590-18297612 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KCTD10 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.562
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:109451018-109451040 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SOD2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:159680231-159680255 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MDN1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:89725305-89725328 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PTP4A1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:63581376-63581397 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EPM2A hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:145626681-145626708 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NPR3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:32788418-32788441 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NR3C1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:143280254-143280282 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ECT2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr3:172769070-172769095 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ACVR2B hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr3:38485161-38485188 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF4G1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr3:184327202-184327225 HITS-CLIP POSITIVE DIRECT TarBase 7.0
INO80D hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.468
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000641-206000659 PAR-CLIP POSITIVE DIRECT TarBase 7.0
LOXL3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.607
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:74533532-74533558 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SF3B1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr2:197398065-197398085 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ODC1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.750
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr2:10440686-10440714 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MSH6 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:47806512-47806531 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC35D1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.484
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr1:67000808-67000834 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WARS2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:119032111-119032138 HITS-CLIP POSITIVE DIRECT TarBase 7.0